Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning.
Options
BORIS DOI
Publisher DOI
PubMed ID
36264524
Description
BACKGROUND
Computational pathology uses deep learning (DL) to extract biomarkers from routine pathology slides. Large multicentric datasets improve performance, but such datasets are scarce for gastric cancer. This limitation could be overcome by Swarm Learning (SL).
METHODS
Here, we report the results of a multicentric retrospective study of SL for prediction of molecular biomarkers in gastric cancer. We collected tissue samples with known microsatellite instability (MSI) and Epstein-Barr Virus (EBV) status from four patient cohorts from Switzerland, Germany, the UK and the USA, storing each dataset on a physically separate computer.
RESULTS
On an external validation cohort, the SL-based classifier reached an area under the receiver operating curve (AUROC) of 0.8092 (± 0.0132) for MSI prediction and 0.8372 (± 0.0179) for EBV prediction. The centralized model, which was trained on all datasets on a single computer, reached a similar performance.
CONCLUSIONS
Our findings demonstrate the feasibility of SL-based molecular biomarkers in gastric cancer. In the future, SL could be used for collaborative training and, thus, improve the performance of these biomarkers. This may ultimately result in clinical-grade performance and generalizability.
Computational pathology uses deep learning (DL) to extract biomarkers from routine pathology slides. Large multicentric datasets improve performance, but such datasets are scarce for gastric cancer. This limitation could be overcome by Swarm Learning (SL).
METHODS
Here, we report the results of a multicentric retrospective study of SL for prediction of molecular biomarkers in gastric cancer. We collected tissue samples with known microsatellite instability (MSI) and Epstein-Barr Virus (EBV) status from four patient cohorts from Switzerland, Germany, the UK and the USA, storing each dataset on a physically separate computer.
RESULTS
On an external validation cohort, the SL-based classifier reached an area under the receiver operating curve (AUROC) of 0.8092 (± 0.0132) for MSI prediction and 0.8372 (± 0.0179) for EBV prediction. The centralized model, which was trained on all datasets on a single computer, reached a similar performance.
CONCLUSIONS
Our findings demonstrate the feasibility of SL-based molecular biomarkers in gastric cancer. In the future, SL could be used for collaborative training and, thus, improve the performance of these biomarkers. This may ultimately result in clinical-grade performance and generalizability.
Date of Publication
2023-03
Publication Type
Article
Keyword(s)
Artificial intelligence Biomarker Blockchain Gastric cancer Pathology Swarm learning
Language(s)
en
Contributor(s)
Saldanha, Oliver Lester | |
Muti, Hannah Sophie | |
Grabsch, Heike I | |
Kohlruss, Meike | |
Keller, Gisela | |
van Treeck, Marko | |
Hewitt, Katherine Jane | |
Kolbinger, Fiona R | |
Veldhuizen, Gregory Patrick | |
Boor, Peter | |
Foersch, Sebastian | |
Truhn, Daniel | |
Kather, Jakob Nikolas |
Additional Credits
Series
Gastric cancer
Publisher
Springer
ISSN
1436-3291
Access(Rights)
open.access